Two Sigma Investments’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-84,300
Closed -$2.29M 5113
2021
Q3
$2.29M Buy
84,300
+401
+0.5% +$9.92K 0.01% 1862
2021
Q2
$1.43M Sell
83,899
-39,784
-32% -$745K ﹤0.01% 2164
2021
Q1
$2.58M Sell
123,683
-99,538
-45% -$2.3M 0.01% 1509
2020
Q4
$5.11M Buy
223,221
+59,814
+37% +$1.14M 0.01% 915
2020
Q3
$2.67M Sell
163,407
-25,537
-14% -$463K 0.01% 1137
2020
Q2
$2.56M Sell
188,944
-47,261
-20% -$550K 0.01% 976
2020
Q1
$2.8M Buy
236,205
+170,805
+261% +$3.79M 0.02% 791
2019
Q4
$1.63M Sell
65,400
-22,100
-25% -$448K ﹤0.01% 1764
2019
Q3
$1.49M Buy
87,500
+23,200
+36% +$422K 0.01% 1655
2019
Q2
$1.46M Buy
64,300
+2,116
+3% +$57.1K ﹤0.01% 1645
2019
Q1
$2M Buy
62,184
+29,487
+90% +$912K 0.01% 1418
2018
Q4
$921K Buy
32,697
+9,793
+43% +$287K ﹤0.01% 1703
2018
Q3
$658K Buy
+22,904
New +$688K ﹤0.01% 2272
2018
Q1
Sell
-144,500
Closed -$4.68M 3652
2017
Q4
$4.68M Buy
144,500
+42,558
+42% +$1.28M 0.02% 936
2017
Q3
$3.17M Buy
101,942
+6,936
+7% +$205K 0.01% 1041
2017
Q2
$2.65M Buy
+95,006
New +$2.15M 0.01% 1233
2015
Q3
Sell
-96,976
Closed -$2.78M 2879
2015
Q2
$2.78M Buy
+96,976
New +$2.54M 0.01% 1021

Other funds holding XENT

Two Sigma Investments's XENT Position: Q4 2021 in Review

Two Sigma Investments sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 84,300 shares — an estimated $2.29M sold.

Two Sigma Investments first reported a position in XENT in Q2 2015 and held it in 17 quarters. The position peaked at $5.11M in Q4 2020. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

  • Two Sigma Investments reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Investments sold 84,300 Intersect ENT, Inc shares in Q4 2021, an estimated $2.29M.
  • Two Sigma Investments first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 17 quarters.
  • Two Sigma Investments's Intersect ENT, Inc position peaked at $5.11M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.